Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: THE ANT who wrote (181240)	12/10/2021 1:12:09 PM
From: gg cox	3 Recommendations Recommended By Cogito Ergo Sum maceng2 Snowshoe Read Replies (1) \| Respond to of 217881

God’s tech support. t.co

To: THE ANT who wrote (181240)	12/10/2021 8:59:18 PM
From: Pogeu Mahone	Respond to of 217881

Everyone hoping you are correct. Is your hospital following Brazil or Fauci? Can you even talk about Brazil at your hospital? The vaxx program is not going away no matter what Brazil does. Germany's Latest Covid Crisis Is Getting Out of Control bloomberg.com › news › articles › german... Nov 18, 2021 — Germany's Coronavirus Crisis Is Getting Out of Control. Deaths have jumped, hospitals are overwhelmed and curbs may be too late. Most reported U.S. Omicron cases have hit the fully vaccinated: CDC MRINALIKA ROY December 10, 2021, 3:28 PM for a week, but actually we have quite a few updates Scroll back up to restore default view. By Mrinalika Roy (Reuters) - Most of the 43 COVID-19 cases caused by the Omicron variant identified in the United States so far were in people who were fully vaccinated, and a third of them had received a booster dose, according to a U.S. report published on Friday. The U.S. Centers for Disease Control and Prevention (CDC) said that of the 43 cases attributed to Omicron variant, 34 people had been fully vaccinated. Fourteen of them had also received a booster, although five of those cases occurred less than 14 days after the additional shot before full protection kicks in. While the numbers are very small, they add to growing concerns that current COVID-19 vaccines may offer less protection against the highly transmissible new variant. The Omicron variant of the coronavirus has been found through testing in about 22 states so far after first being identified in southern Africa and Hong Kong in late November. Among the Omicron cases, 25 were in people aged 18 to 39 and 14 had traveled internationally. Six people had previously been infected with the coronavirus. Most of them only had mild symptoms such as coughing, congestion, and fatigue, the report said, and one person was hospitalized for two days. Other symptoms reported less frequently including nausea or vomiting, shortness of breath or difficulty breathing, diarrhea and loss of taste or smell. The CDC said that while many of the first reported Omicron cases appear to be mild, a lag exists between infection and more severe outcomes. Symptoms would also be expected to be milder in vaccinated persons and those with previous SARS-CoV-2 infection. The first known U.S. Omicron case was identified reut.rs on Dec 1 in a fully vaccinated person who had traveled to South Africa. The CDC said that the earliest date of symptom onset was Nov. 15 in a person with a history of international travel. The Delta variant still accounts for more than 99% of all U.S. cases. But reports from South Africa show that the Omicron variant is very transmissible. Even if most cases are mild, a highly transmissible variant could result in enough infections to overwhelm health systems, the CDC cautioned. Laboratory studies released this week suggest that the Omicron variant will blunt the protective power of two doses of Pfizer and BioNTech's COVID-19 vaccine, although a third dose reuters.com may restore that protection. The U.S. has authorized COVID-19 vaccine booster reuters.com for all Americans age 16 and older. (Reporting by Mrinalika Roy in Bengaluru; Editing by Caroline Humer and Bill Berkrot)

To: THE ANT who wrote (181240)	12/11/2021 7:57:08 AM
From: Pogeu Mahone	Respond to of 217881

COVID-19: THE LATEST CDC identifies 43 Omicron infections in 22 states; National Guard helping areas overwhelmed by COVID-19 bostonglobe.com

To: THE ANT who wrote (181240)	12/15/2021 10:24:22 AM
From: Pogeu Mahone	Read Replies (1) \| Respond to of 217881

"We will know in a week whether Omicron if friend or foe." I say foe 5 days after your post. Did Omicron infections double yesterday? Omicron can hit fully vaccinated, Oxford study says, as UK prepares for tidal wave of cases PUBLISHED MON, DEC 13 20216:34 AM ESTUPDATED TUE, DEC 14 202111:21 AM EST Chloe Taylor @CHLOETAYLOR141 KEY POINTS In a new study announced on Monday, researchers from the University of Oxford tested blood samples of people 28 days after their second dose of either the Oxford-AstraZeneca or Pfizer-BioNTech vaccine.When omicron was introduced to those samples, scientists reported “a substantial fall” in the neutralizing antibodies that fight off Covid compared to the immune responses seen against earlier variants. VIDEO01:39 LONDON — Two doses of the Oxford- AstraZeneca or Pfizer- BioNTech Covid-19 vaccines are substantially less effective at warding off omicron compared to previous variants of the coronavirus, scientists have found. However, the researchers were optimistic that a booster shot would improve immunity against the new, highly transmissible variant. In a new study announced on Monday, researchers from the University of Oxford tested blood samples of people 28 days after their second dose of either vaccine. When omicron was introduced to those samples, scientists reported “a substantial fall” in the neutralizing antibodies that fight off Covid compared to the immune responses seen against earlier variants. The research paper noted that some vaccine recipients “failed to neutralize [the virus] at all.” “This will likely lead to increased breakthrough infections in previously infected or double vaccinated individuals, which could drive a further wave of infection, although there is currently no evidence of increased potential to cause severe disease, hospitalization or death,” the study’s authors said. The pre-print study, which is yet to be peer reviewed, was published on the MedRxiv server. Gavin Screaton, head of Oxford University’s Medical Sciences Division and lead author of the paper, said in a press release on Monday that the findings should “press home the message that those who are offered booster vaccination should take it.” “Whilst there is no evidence for increased risk of severe disease, or death, from the virus amongst vaccinated populations, we must remain cautious, as greater case numbers will still place a considerable burden on healthcare systems,” he warned. WATCH NOW VIDEO04:11 It’s unclear whether we need an omicron-specific vaccine, says Dr. Ofer Levy “Vaccination induces many arms of our immune system, including neutralizing antibodies and T-cells,” added co-author Teresa Lambe, a professor of vaccinology at the University of Oxford. “Real-world effectiveness data has shown us that vaccines continue to protect against severe disease with previous variants of concern. The best way to protect us going forward in this pandemic is by getting vaccines in arms.” A report published by the U.K.’s Health Security Agency on Friday estimated that two doses of a Covid vaccine were significantly less effective at preventing symptomatic disease through infection from the omicron variant compared to delta. However, the report noted that after a booster dose, vaccines were thought to be 70 to 75% effective at preventing symptomatic infections. “With previous variants, vaccine effectiveness against severe disease, including hospitalization and death, has been higher than effectiveness against mild disease,” the UKHSA said. “It will be a few weeks before effectiveness against severe disease with Omicron can be estimated, however based on this experience, this is likely to be substantially higher than the estimates against symptomatic disease.” In a televised statement on Sunday, U.K. Prime Minister Boris Johnson warned Britain faces a “tidal wave” of Omicron infections, and announced that the country would be speeding up its booster program to offer all adults a third dose of a vaccine by the end of the year. The government had previously been aiming to extend its booster scheme to all over-18s by the end of January. ================================ Still deaths around 22 a day in South Africa We will know in a week whether Omicron if friend or foe. Brasil at herd immunity but no one talking. Just imagine the evil people who suffer when the news is good. Everyone who reads this and hopes Im wrong is evil